About C20/20 Innovation Hub

The C20/20 Innovation Hub at McMaster University is a partner research organization specializing in the development and commercialization of biomaterials and drug delivery with expertise in the mitigation of ocular disorders. 

Our interdisciplinary team of scientists and engineers take a global view of the translational pipeline, providing expert support at any point in your early development pipeline. Our expertise ranges from early stage chemistry, synthesis and material design to in vitro drug delivery, assays and characterization through to non-GLP preclinical validation. 

Located within McMaster University in Hamilton, Ontario, a world-class institution, we strive for scientific excellence, coupling our highly-trained staff with state-of-the-art equipment. This includes in vitro and in vivo services, with in-house contact lens, histology and bioanalytical capabilities for ocular and other disease projects.

Our expert personnel work closely with private sector partners and internal collaborators, providing strategic guidance and testing services to deliver excellent science and valuable insights as an extension of your team. We are able to respond to your unique challenge with a tailored solution, maximizing your value as you move confidently from bench toward the bedside. Our fast and flexible study arrangements allow for project-by-project collaborations, with customized milestones, timelines and intellectual property terms for companies of all sizes. We are able to support your early research and all stages of preclinical development, significantly accelerating the development pathway for numerous clients.